3Eff

What 3Eff does

3Eff S.A. is a Buenos Aires-based health economics and outcomes research (HEOR) consultancy founded in November 2004 by Mariana Laura Glancszpigel. The firm serves pharmaceutical and medical device companies operating in Argentina, with supplemental offerings aimed at the country's three healthcare financing systems—social security, private, and public. Services span clinical research (epidemiological registries, clinical trials, patient-reported outcomes, regulatory affairs, data management, and biostatistics) and health economics (Delphi panels, budget impact modeling, cost-effectiveness modeling, systematic reviews, and GRADE evidence quality assessment).

The company's technical footprint centers on two proprietary platforms: 3mec, a standardized pharmacoeconomics platform providing adapted budget impact and cost-effectiveness models, evidence quality assessment tools, and calculator development; and 3val, an integrated health costs database covering all three Argentine health sectors with standardized nomenclature and an adverse events module. Both products are positioned as supplements to the firm's professional services rather than standalone enterprise software offerings, and are supported by a multidisciplinary team spanning statistics, medicine, epidemiology, IT, economics, and marketing.

Commercially, 3Eff operates a sales-led, professional services model with direct client engagement as the primary distribution channel. Revenue streams include custom consulting engagements for clinical and economics work, a recurring subscription/membership component for 3mec, and managed services for the 3val health costs database. The company maintains a single-country footprint in Argentina, a headcount of 1-10 employees, and uses academic publications and ISPOR conference participation as its primary marketing channels. No external funding rounds, acquisitions, or institutional investors have been disclosed.

Name

3Eff

Legal name

3eff S.A.

Website

https://3eff.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

3Eff S.A. is a Buenos Aires-based health economics consultancy serving pharmaceutical and medical device companies in Argentina. It operates two proprietary platforms—3mec for pharmacoeconomic modeling and 3val for standardized health costs data—supplemented by clinical research and HEOR consulting services.

Ownership category

akta.pro rank

Headquarters

HQ city

City Bell

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Consulting Services - Clinical: Professional services for epidemiological registries, clinical trials, patient reported outcomes, protocol design, regulatory affairs, monitoring, clinical data management, statistics, and project management.
2. Economics Services: Services including Delphi panels, interviews, budget impact models, cost-effectiveness models, systematic reviews, and GRADE evidence quality assessment.
3. 3mec Membership: Annual subscription/access to standardized pharmacoeconomics platform providing tools for operational and financial planning with reduced administrative timelines and costs.
4. 3val Health Costs Service: Integrated health costs database service covering Argentinean health sectors (social security, private, and public systems) with adverse events module and user help desk.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

3Eff S.A. is a Buenos Aires-based healthcare consultancy that delivers health economics and outcomes research (HEOR) services to the pharmaceutical and medical device industries. It operates two proprietary platforms: 3mec, a standardized pharmacoeconomics services platform providing budget impact models, cost-effectiveness models, and evidence quality assessment tools; and 3val, an integrated health costs database covering Argentina's social security, private, and public healthcare sectors with standardized nomenclature and adverse events tracking.

Product overview

3Eff S.A. is a consultancy firm in the health research area offering two core products: 3mec and 3val. 3mec is a standardized annual pharmacoeconomics services platform providing budget impact analysis models, cost-effectiveness models adaptation, and evidence quality assessment tools. 3val is an integrated health costs database service offering unit costs data across all three Argentinean health sectors (social security, private, and public) plus an adverse events module. The company also provides clinical and economic consulting services.

Differentiator

Problem solved

Functional benefit

Brands

• 3mec: Standardized pharmacoeconomics services platform offering budget impact analysis models adaptation, cost-effectiveness models adaptation, evidence quality assessment, and calculator development for budget impact analysis.
• 3val

Products and services

• 3mec Standardized pharmacoeconomics services platform covering budget impact analysis models adaptation, cost-effectiveness models adaptation, evidence quality assessment, and calculator development tools for budget impact analysis. Sold as an annual subscription/membership to pharmaceutical and medical device companies for operational and financial planning in Argentina.
• 3val Integrated health costs service including a unit costs database of health services based on nomenclature standardization, a module of adverse events based on standardized medical terminology under international standards, and a user help desk. Covers Argentine social security, private, and public healthcare systems.
• Clinical Research Services Professional consulting services covering epidemiological registries, clinical trials, patient reported outcomes, protocol design, regulatory affairs, monitoring, clinical data management, statistics, and project management for pharmaceutical and medical device companies.
• Economics Consulting Services Professional services including Delphi panels, interviews, budget impact models, cost-effectiveness models, systematic reviews, and GRADE evidence quality assessment for healthcare clients.

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• RTI Health Solutions: Not-for-profit HEOR and patient-centered outcomes research consultancy serving pharmaceutical, biotech, and medical device clients. Direct peer in evidence synthesis, economic modeling, and health technology assessment work that 3Eff delivers through 3mec and clinical services.
• BresMed Health Solutions: Specialist HEOR and market access consultancy providing economic modeling, systematic reviews, and HTA support to pharma. Direct functional peer to 3Eff on cost-effectiveness and budget impact modeling, though UK-based rather than Latin American.
• Xcenda (AmerisourceBergen / Cencora): Consultancy supporting pharma and biotech with health economics, outcomes research, and market access strategies. Comparable offering to 3Eff's standardized pharmacoeconomics and clinical services for reimbursement and coverage decisions.
• Evidera (PPD / Thermo Fisher Scientific): Dedicated HEOR, market access, and real-world evidence consultancy serving pharma and medtech. Closest functional analog to 3Eff: it provides health economic modeling, budget impact analysis, and value communications that map directly onto 3Eff's 3mec service scope.
• Cytel: Clinical analytics and HEOR firm (including via the Pharmerit acquisition) providing biostatistics, real-world evidence, and health economics services. Comparable to 3Eff in combining statistics, epidemiology, and health economics expertise for pharma market access engagements.
• Pharmerit International (now part of Cytel): Specialized HEOR and market access consulting firm now integrated with Cytel. Direct functional overlap with 3Eff's budget impact, cost-effectiveness modeling, and evidence assessment services for pharmaceutical clients.

Emerging players

• Wickenstones: HEOR and market access consultancy delivering economic modeling, evidence synthesis, and value communication for life sciences clients. Comparable to 3Eff on HEOR modeling and health economics deliverables, though UK-headquartered and not focused on Argentina.

Broad incumbents

• IQVIA: Global clinical research and HEOR powerhouse offering real-world evidence, health economics, and market access services to pharma and medtech clients. Directly competes with 3Eff in HEOR/pharmacoeconomics consulting, but at much larger scale and across many geographies rather than specializing in Argentina.
• ICON plc: Global CRO with a dedicated HEOR and real-world evidence practice serving pharmaceutical and medical device sponsors. Overlaps with 3Eff on health economics, outcomes research, and market access support, but ICON operates a global delivery model rather than a single-country specialty.
• PAREXEL International (now part of EQT / Goldman Sachs): Global CRO with significant HEOR, real-world evidence, and market access capabilities for pharmaceutical and medical device sponsors. Overlaps with 3Eff on clinical data management and health economics, but as part of a much broader clinical and regulatory portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/3eff_
• LinkedInlinkedin.com/company/3eff
• Instagraminstagram.com/3eff.research

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3Eff